Socías ME, Scheuermeyer FX, Cui Z, Mok WY, Crabtree A, Fairbairn N, Nolan S, Slaunwhite A, Ti L Using a cascade of care framework to identify gaps in access to medications for alcohol use disorder in British Columbia, Canada Addiction PubMed

Duncan K, Scheuermeyer F, Lane D, Ahamad K, Moe J, Dong K, Nolan S, Buxton J, Miles I, Johnson C, Christenson J, Whyte M, Daoust R, Garrod E, Badke K, Kestler A Patient opinion and acceptance of emergency department buprenorphine/naloxone to-go home initiation packs CJEM PubMed

Bahji A, Bastien G, Bach P, Choi JC, Le Foll B, Lim R, Jutras-Aswad D, Socías ME The association between self-reported anxiety and retention in opioid agonist therapy: findings from a Canadian pragmatic trial Can J Psychiatry PubMed

Elefante J, Nolan S, Bach P RE: Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada CMAJ Link

Klaire S, Fairbairn N, Ryan A, Nolan S, McLean M, Bach P Safety and efficacy of rapid methadone titration for opioid use disorder in an inpatient setting: a retrospective cohort study J Addict Med PubMed

Socías ME, Choi JC, Fairbairn N, Johnson C, Wilson D, DeBeck K, Brar R, Hayashi K Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: an interrupted time series analysis Int J Drug Policy PubMed

Cui Z, Hayashi K, Bach P, Milloy MJ, Kerr T Crystal methamphetamine use and methadone maintenance treatment dissatisfaction: a prospective cohort study in Vancouver, Canada J Subst Use Addict Treat PubMed